NIH selects Emergex’s T cell vaccine for trials under Project NextGen
As part of the development, NIAID is expected to cover the entire cost of the Phase I clinical trial.
Covid-19
Moderna blamed after children offered £1,500 to take part in Covid-19 trial
Testosterone could influence men’s immune response to Covid-19
As mpox spreads, ‘national governments have a moral responsibility to help’
What is mpox and how big of a threat is it?
Entos and Aegis announce dosing of first subject in Covid-19 vaccine trial
AB Science touts positive Phase II Covid-19 data for masitinib
NIH announces start of subject enrolment for nasal Covid-19 vaccine trial
